Cleveland Clinic Abu Dhabi launches comprehensive Invasive Microvascular and Coronary Spasm Program testing in the UAE

Cleveland Clinic Abu Dhabi launches comprehensive Invasive Microvascular and Coronary Spasm Program testing in the UAE

- This condition can affect people even if their coronary arteries show no significant blockages on a standard angiogram

- Women are more likely to experience symptoms of microvascular angina than males

- Cleveland Clinic Abu Dhabi introduces groundbreaking technology for both microvascular and spasm-invasive testing in the UAE

Abu Dhabi, United Arab Emirates: Cleveland Clinic Abu Dhabi, a Mubadala Health partner, continues to be the catalyst for complex care in the region with the launch of an Invasive Microvascular and Coronary Spasm Program in the UAE. The invasive test evaluates for a cardiac disorder that causes angina (chest pain) due to the arteries that supply blood to the heart either spasming down or failing to dilate adequately, which can go undetected in routine cardiac tests.

Cleveland Clinic Abu Dhabi introduced a complete microvascular dysfunction and coronary spasm program in the UAE. The highly sophisticated testing method calls for specialized interventional cardiologists along with specialized equipment that can screen for abnormalities not only in the large coronary arteries but also the extremely minute arteries that are undetectable to the human eye. Without sophisticated testing, this condition will not be detected by the standard coronary artery angiogram and such patients end up suffering from recurrent